These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6400575)

  • 21. Profile of cytokines in aqueous humor from corneal graft recipients.
    Dekaris I; Gabrić N; Mazuran R; Karaman Z; Mravicić I
    Croat Med J; 2001 Dec; 42(6):650-6. PubMed ID: 11740849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in cytokine mRNA levels in experimental corneal allografts after local clodronate-liposome treatment.
    Torres PF; Slegers TP; Peek R; van Rooijen N; van der Gaag R; Kijlstra A; de Vos AF
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3194-201. PubMed ID: 10586942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue-engineered human corneal endothelial cell sheet transplantation in a rabbit model using functional biomaterials.
    Lai JY; Chen KH; Hsiue GH
    Transplantation; 2007 Nov; 84(10):1222-32. PubMed ID: 18049106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limbal allografting from related live donors for corneal surface reconstruction.
    Rao SK; Rajagopal R; Sitalakshmi G; Padmanabhan P
    Ophthalmology; 1999 Apr; 106(4):822-8. PubMed ID: 10201609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial keratoplasty using donor tissue not suitable for full-thickness penetrating keratoplasty.
    Armour RL; Ousley PJ; Wall J; Hoar K; Stoeger C; Terry MA
    Cornea; 2007 Jun; 26(5):515-9. PubMed ID: 17525642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Internal and external contamination of donor corneas before in situ excision: bacterial risk factors in 93 donors.
    Robert PY; Camezind P; Drouet M; Ploy MC; Adenis JP
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):265-70. PubMed ID: 11981639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of eye bank-prepared posterior lamellar corneal tissue for endothelial keratoplasty.
    Rose L; Briceño CA; Stark WJ; Gloria DG; Jun AS
    Ophthalmology; 2008 Feb; 115(2):279-86. PubMed ID: 17599413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular penetration of topical Delta9-tetrahydrocannabinol from rabbit corneal or cul-de-sac application site.
    Green KE; Kearse CE
    Curr Eye Res; 2000 Jul; 21(1):566-70. PubMed ID: 11035538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
    Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution.
    Fukuda M; Inoue A; Sasaki K; Takahashi N
    Jpn J Ophthalmol; 2004; 48(2):93-6. PubMed ID: 15060787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Limbal stem cell transplantation from HLA-compatible living donors. Long term observation].
    Wylegała E; Tarnawska D; Wróblewska EM
    Klin Oczna; 2003; 105(6):378-83. PubMed ID: 15049259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Australian Corneal Graft Registry. 1990 to 1992 report.
    Aust N Z J Ophthalmol; 1993 May; 21(2 Suppl):1-48. PubMed ID: 8333942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.
    Zheng X; Marquart ME; Loustch JM; Shah P; Sainz B; Ray A; O'Callaghan RJ; Kaufman HE; Hill JM
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2490-7. PubMed ID: 10509641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of corneal graft survival in infants and children with peters anomaly.
    Yang LL; Lambert SR; Lynn MJ; Stulting RD
    Ophthalmology; 1999 Apr; 106(4):833-48. PubMed ID: 10201611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Corneal wound healing after penetrating keratoplasty with EGF application. Experimental studies].
    Szaflik J; Fryczkowski AW; Liberek I; Czubak M; Brix M; Broniek G; Fryczkowski P
    Klin Oczna; 1999; 101(6):409-16. PubMed ID: 10786046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue utilization at the Minnesota Lions' Eye Bank.
    Moyes AL; Holland EJ; Palmon FE; Dvorak JA; Doughman DJ
    Cornea; 1995 Nov; 14(6):571-7. PubMed ID: 8575175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin.
    Kuehne JJ; Yu AL; Holland GN; Ramaswamy A; Taban R; Mondino BJ; Yu F; Rayner SA; Giese MJ
    Am J Ophthalmol; 2004 Oct; 138(4):547-53. PubMed ID: 15488779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental study on corneal organ culture preservation and its application].
    Liu T; Pan ZQ; Wang L; Li N
    Zhonghua Yan Ke Za Zhi; 2006 Sep; 42(9):808-13. PubMed ID: 17173742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.